The specifications in Acemoglu and Johnson ð2006, 2007Þ allowed for potential long-run effects of health improvements and supported our empirical strategy by showing that changes in the predicted mortality instrument were uncorrelated with its own past changes and past changes in population, GDP, and GDP per capita. There are three further ways to assess Bloom et al.'s concerns. First, we include the initial level of life expectancy from 1900, interacted with time dummies in our decadal panel data set ðwhich runs from 1940Þ. Second, we use a nonlinear estimator suggested by Bloom et al.' s framework to estimate directly their proposed equation with reasonable precision. Third, from microeconomic estimates in Ashraf, Lester, and Weil ð2008Þ, we calculate potential macroeconomic effects of current life expectancy on future growth and examine the implications for our baseline findings. Our results remain robust throughout.
II. The Estimating Framework
Our estimating equation in Acemoglu and Johnson ð2006, 2007Þ was
Here i denotes country and t is time period; y is log GDP per capita; x is log life expectancy ðat birth or at other agesÞ; the z i 's denote a full set of fixed effects to capture cross-country differences in time-invariant characteristics; the m t 's incorporate time-varying factors common across all countries; and Z it denotes a vector of other controls. ðWe use the subscript it 1 k as shorthand for i, t 1 k.Þ The case in which k > 0 allows for lagged effects of life expectancy. We instrumented life expectancy with predicted mortality, constructed as
where M dit denotes mortality in country i from disease d at time t, I dt is a dummy for intervention on disease d at time t ðequal to one for all dates after the interventionÞ, and D denotes a set of 15 infectious diseases for which we have data, including most major communicable causes of death around the world in 1940, as well as some less common killers. The variable M di40 refers to the pre-intervention mortality from disease d in the same units, while M dFt is the mortality rate from disease d at the health frontier of the world at time t. For our baseline instrument, M dFt is set equal to zero. Any change in life expectancy is unlikely to have its full effect on any demographic or economic variables instantaneously-or even in the same decade. For this reason, in Acemoglu and Johnson ð2007Þ, we estimated equation ð1Þ in long differences, that is, regressing change on change in a panel including only two years, t 0 and t 1 ðin practice 1940 and 1980 or 1940 and 2000Þ . In Acemoglu and Johnson ð2006Þ, we also presented a range of panel specifications using decadal observations; these results were very similar to those from the long-difference specifications that were emphasized in Acemoglu and Johnson ð2007Þ. We explicitly discussed the adjustment dynamics of population and GDP and allowed for potential health effects to show up after a long lag: after 40 or 60 years in the long-difference specifications and with 10-, 20-, 30-, or 40-year horizons in panel specifications.
Bloom et al. propose a "partial adjustment model" that takes the following form: 1
where Dy it ; y it 2 y it21 , and Dx it is defined similarly. They derive this from our equation ð1Þ, assuming an ARð1Þ specification for the error term ðε it 5 lε it21 1 y it Þ. This equation allows for convergence dynamics ðthrough the l termÞ and a potential impact of the lagged level of log life expectancy, x it21 , on subsequent changes in GDP per capita. 
III. The Impact of Initial Life Expectancy

A. Controlling for Initial Life Expectancy
To facilitate comparison with models that control for the effect of initial life expectancy, column 1 of table 1 reports baseline estimates of ð1Þ using decadal observations as in the panel data models of Acemoglu and Johnson ð2006Þ. Panel A is for 1940-80 and panel B is for 1940-2000. 3 The standard errors in this and subsequent models are robust and allow for arbitrary serial correlation at the country level. In column 1 of panel A,p 5 21:307, with a standard error ðSEÞ of 0.455, indicating a negative impact of life expectancy on GDP per capita. Column 1 of panel B shows a similar estimate that is larger in absolute value ði.e., more negativeÞ for the period 1940-2000,p 5 21:394. 4 The remaining columns in table 1 include a full set of time interactions with log life expectancy in 1900-allowing initial life expectancy to flexibly affect future GDP per capita. Using the 1900 value for life expectancy rather than the 1940 level alleviates the mechanical correlation between 1940 life expectancy and predicted mortality. It is equally valid if there is an impact from the level of initial life expectancy on future growth as proposed by Bloom et al. 5 Column 2 shows results from including these interactions without controlling for lagged GDP per capita. In panel A, the estimate isp 5 20:100 ðSE 5 0.421Þ. Thus there is a negative ðand far from significantÞ 3 We have data on GDP, life expectancy, and other variables of interest every 10 years from 1940 to 2000. We also look at the period 1940-80 to avoid the potential effects of the onset of HIV-AIDS as a global disease. 4 These balanced panel estimates are very close to those reported in cols. 1 and 2 of the unbalanced panel of table 11 in Acemoglu and Johnson ð2006Þ and to the long differences in cols. 1 and 2 of table 7, panel B, in Acemoglu and Johnson ð2007Þ.
5 Econometrically, we are controlling for the effects of initial life expectancy by including a full set of time dummies interacted with initial life expectancy, i.e., terms of the form q t Â x i1900 ðone for each t Þ. This strategy potentially controls for two types of effects. The first is that life expectancy in 1900, x i 1900 , directly affects outcomes in subsequent years. The second is that the year t equation contains the term q t Â x it21 ðthus allowing for a general impact of lagged life expectancyÞ. In this latter case, we can substitute for x it21 in terms of log life expectancy in 1900, x i 1900 . For example, following the model for the dynamics of life expectancy estimated in table 6 of Acemoglu and Johnson ð2007, 957, eq. ½12Þ, suppose that x it 5 nx it21 1 h it , with decadal observations and h it being serially uncorrelated and orthogonal to other variables. Then substitute for x it21 and its lags successively to obtain x it21 5 n t21 x i1900 1 h it21 1 nh it22 1 n 2 h it23 1 Á Á Á, with x i 0 5 x i1900 . Then the coefficient on x it21 in the year t equation would be q t Â n t21 , and all other coefficients can be estimated consistently.
impact of life expectancy on GDP per capita, which is much smaller than the estimate in column 1. The estimate in panel B ðp 5 20:928, SE 5 0.486Þ is larger in absolute value ði.e., more negativeÞ, much closer to the estimate in column 1, and marginally statistically significant.
In addition to year dummies interacted with initial life expectancy, column 3 adds a full set of time interactions with log GDP per capita in 1940. These interactions are useful since any correlation with initial GDP per capita might otherwise load onto initial life expectancy. In panel A, we now estimatep 5 20:270 ðSE 5 0.522Þ. The coefficient on life expectancy in panel B is larger, 21.317, very similar to our baseline estimate in column 1, and statistically significant at 5 percent ðSE 5 0.627Þ.
Columns 4 and 5 add lagged log GDP per capita to the right-hand side, allowing for convergence effects. These two columns, respectively, use the standard two-stage least-squares ð2SLSÞ estimator and Arellano and Bond's ð1991Þ optimally weighted two-step generalized method of moments ðGMMÞ estimator, with predicted mortality as the external instrument. The results are again broadly consistent with our baseline results. The GMM estimate in column 5 isp 5 20:171 ðSE 5 0.393Þ in the 1940-80 panel and a larger ðin absolute valueÞ, more precise, and statistically significantp 5 20:598 ðSE 5 0.234Þ in the 1940-2000 panel.
Overall, controlling for the effects of initial life expectancy changes our point estimates, especially for the 1940 -80 period. However, in no case is there any evidence for a positive effect of life expectancy on GDP per capita, and the estimates in table 1 for 
C. Directly Incorporating Lagged Effects of Life Expectancy
An alternative strategy is to directly incorporate the potential effect of initial life expectancy in the long-difference specification from Acemoglu and Johnson ð2007Þ. Rewriting Bloom et al.'s estimating equation gives Dỹ it ; Dy it 2 kx it21 5 pDx it 2 ly it21 1 a t 1 y it :
ð4Þ journal of political economy
Although we do not know the precise value of k ð5 lpÞ, the microeconomic literature-surveyed by Ashraf et al. ð2008Þ-provides guidance on how large this could be. Specifically, we use their estimates to obtain an upper bound for plausible values of k by supposing that all the potential effects of initial life expectancy are captured by k.
In our sample, life expectancy among the countries with high initial mortality increased from about 40 to over 60 between 1940 and 1980. Increasing median life expectancy from 40 to 60 years would, according to Ashraf et al.'s base estimate, raise GDP per capita by 15 percent in the long run ðover 60 yearsÞ. When their high estimate is used-which assumes that all impacts of health are as positive as any microeconomic study could suggest-the increase in GDP per capita is 25 percent and the full long-run effect is achieved within 40 years.
In terms of equation ð4Þ, supposing that the 15 percent long-run effect is all captured by k, this would imply a value of k equal to 0.343, while a 25 percent long-run effect implies that k 5 0:54. 7 We use k 5 0:3, 0.4, 0.5, and 0.6 to span a range for the upper bound for the effects of increased life expectancy on future growth. The estimate of 0.6, in particular, represents the strongest possible case for the Bloom et al. hypothesis. We estimate equation ð4Þ using 2SLS in two sets of specifications. First, we estimate ð4Þ assuming no mean reversion, that is, setting l 5 0 ðoddnumbered columns in table 2Þ. Second, we estimate ð4Þ including log GDP per capita in 1940 on the right-hand side to control for potential convergence effects in GDP per capita ðeven-numbered columns in table 2Þ. In either case, there is no evidence of a positive coefficient for p. As shown in table 2, every 0.1 increase in k reduces the negative effect of life expectancy by about 0.15 in absolute terms. This implies that to reach even a zero coefficient on change in life expectancy for the oddnumbered columns of panel A ðfor 1940-80 and without controlling for GDP per capita in 1940Þ would require a k of around 0.9. This is far larger than anything that can reasonably be supported using the available microeconomic evidence. To imagine a positive effect for life 7 We translate between Ashraf et al.'s simulation parameters and our regression coefficients as follows. A 15 percent increase in GDP per capita means that the level of GDP per capita ends up at 1.15 ði.e., if it starts at 1Þ, so the impact measured in natural logarithms is lnð1.15Þ 5 0.139. Initial life expectancy is 40 years and lnð40Þ 5 3.69. Final life expectancy is 60 years and lnð60Þ 5 4.09. The change in log life expectancy is 0.405. Assuming that all of this is accounted for by k gives an upper bound for k 5 ð0:139=0:405Þ 5 0:343 in the base case. Note.-2SLS estimates of eq. ð8Þ, from the text, assuming different values for k. 
IV. Conclusion
Estimates using 40-year or 60-year differences in Acemoglu and Johnson ð2006, 2007Þ, which should capture any slow-acting effects of health improvements, did not show any evidence for a positive impact of life expectancy on GDP per capita. In this note, we report three additional approaches for assessing the potential effects of initial life expectancy on subsequent changes in GDP per capita. All these approaches confirm that our main results are robust: there is no evidence that increases in life expectancy after 1940 had a positive effect on GDP per capita growth.
